NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
Department of Health and Human Services
Description
Overview
- Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Program: Trans-Omics for Precision Medicine (TOPMed) 2.0
- Focus: Generate and share large-scale multi-omics data to uncover molecular mechanisms of heart, lung, blood, and sleep (HLBS) disorders, including rare diseases.
What this opportunity provides
- No direct funding to applicants.
- NHLBI will generate and process omics data from your existing, well-phenotype…
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership in research, training, and education to promote the prevention and treatment of heart, lung, blood and sleep disorders. NHLBI's mission covers many common diseases, such as heart disease and chronic respiratory dise…
Source
Grant ID
PAR:PAR-25-447.html
Agency
Department of Health and Human Services
Similar opportunities
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
Department of Health and Human Services
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
Department of Health and Human Services
- Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)
National Institutes of Health
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Department of Health and Human Services
- Notice of Funding Opportunity (NOFO) for NIH INCLUDE Project
National Institutes of Health